A Phase II, Randomized Study of the Use of Rucaparib Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2019
At a glance
- Drugs Rucaparib (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 14 Jan 2019 Planned initiation date changed from 1 Dec 2018 to 1 Jun 2019.
- 30 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Dec 2018.
- 13 Aug 2018 New trial record